These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 6754634)

  • 41. A pilot trial of labetalol (AH 5158A): a combined alpha and beta blocker in treatment of hypertension.
    Dent R; Kellaway GS
    N Z Med J; 1977 Sep; 86(595):213-5. PubMed ID: 305013
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical pharmacology of hypertension: amelioration of left ventricular performance by treatment with labetalol.
    Belogi M; Ansuini R; Pupita G; Campolucci G; Pupita F
    Int J Clin Pharmacol Res; 1984; 4(5):385-7. PubMed ID: 6519853
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Arterial hypertension in the elderly. Double-blind study versus placebo of the efficacy and tolerability of an alpha-beta blocker: labetalol].
    Forette F; Henry-Amar M; d'Allens H; Hervy MP; Bouchacourt P; Henry JF; Pappo M
    Ann Cardiol Angeiol (Paris); 1987 Feb; 36(2):103-7. PubMed ID: 3827157
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Treatment of severe hypertension by repeated bolus injections of labetalol.
    Cumming AM; Brown JJ; Lever AF; Mackay A; Robertson JI
    Br J Clin Pharmacol; 1979; 8(Suppl 2):199S-204S. PubMed ID: 393288
    [No Abstract]   [Full Text] [Related]  

  • 45. Labetalol in long-term treatment of hypertension.
    Prichard BN; Boakes AJ
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):743-50. PubMed ID: 62582
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Comparative effects of an alpha 1 and beta 1-2 blocker (labetalol) and a beta-1 blocker (atenolol) in the hypertensive patient].
    Sassard J; Zech PY; Pozet N; Cuisinaud G; Vincent M
    J Pharmacol; 1983; 14 Suppl 2():121-9. PubMed ID: 6355664
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Essential arterial hypertension. Effects of labetalol on blood pressure and renin-angiotensin system (author's transl)].
    Martinand A; Lardoux H; Corvol P; Milliez P
    Nouv Presse Med; 1980 Sep; 9(35):2565-8. PubMed ID: 7001349
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The anti-hypertensive efficacy of combined alpha- and beta-adrenoreceptor blockade with phentolamine-oxprenolol or with labetalol (AH 5158).
    Johnson BF; LaBrooy J; Munro-Faure AD
    Clin Sci Mol Med Suppl; 1976 Dec; 3():505s-507s. PubMed ID: 799558
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Labetalol in the treatment of patients with hypertension and renal function impairment.
    Bailey RR
    Br J Clin Pharmacol; 1979; 8(Suppl 2):135S-140S. PubMed ID: 526393
    [No Abstract]   [Full Text] [Related]  

  • 50. [Use of labetalol in the treatment of hypertensive crises].
    Semplicini A; Pessina AC; Rossi GP; Palatini P; Hlede M; Morandin F; Visonà A; Mazzucato A; Dal Palù C
    G Ital Cardiol; 1982; 12(5):355-8. PubMed ID: 7152187
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Labetalol as a hypotensive agent in otological operations.
    Pakkanen A; Kanto J
    Ann Chir Gynaecol; 1979; 68(2):82-3. PubMed ID: 41475
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of labetalol and propranolol in treatment of hypertension.
    Harvald B
    Postgrad Med J; 1980; 56 Suppl 2():65-8. PubMed ID: 7433346
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Systolic time intervals in essential hypertension. II. Variations produced by treatment with labetalol].
    Rossi A; Ziacchi V; Lomanto B
    Arch Mal Coeur Vaiss; 1979 Nov; 72(11):1240-6. PubMed ID: 121529
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparative anti-hypertensive effects of labetalol and the combination of oxprenolol and phentolamine.
    Johnson BF; LaBrooy J; Munro-Faure AD
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):783-7. PubMed ID: 791332
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of labetalol, clonidine and diazoxide intravenously administered in severe hypertension.
    Yeung CK; Thomas GW; Whitworth JA; Kincaid-Smith P
    Med J Aust; 1979 Nov; 2(9):499-500. PubMed ID: 522807
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A controlled trial of labetalol (Trandate), propranolol and placebo in the management of mild to moderate hypertension.
    Pugsley DJ; Nassim M; Armstrong BK; Beilin L
    Br J Clin Pharmacol; 1979 Jan; 7(1):63-8. PubMed ID: 367410
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of effects on cerebral blood flow of rapid reduction in systemic arterial pressure by diazoxide and labetalol in hypertensive patients: preliminary findings.
    Pearson RM; Griffith DN; Woollard M; James IM; Havard CW
    Br J Clin Pharmacol; 1979; 8(Suppl 2):195S-198S. PubMed ID: 526401
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Acute hemodynamic effect of labetalol in severe hypertension].
    Omvik P; Lund-Johansen P
    Tidsskr Nor Laegeforen; 1980 Nov; 100(33):1971-4. PubMed ID: 7456057
    [No Abstract]   [Full Text] [Related]  

  • 59. Use of labetalol in the treatment of severe hypertension during pregnancy.
    Michael CA
    Br J Clin Pharmacol; 1979; 8(Suppl 2):211S-215S. PubMed ID: 526403
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Effects of labetalol, a new alpha- and beta-adrenoreceptor blocking drug, on arterial pressure, renal function and renin activity (author's transl)].
    Zech P; Pozet N; Sassard J; Vincent M
    Nouv Presse Med; 1980 Mar; 9(15):1087-90. PubMed ID: 7008020
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.